Novartis reports mixed Q4 results; initates FY26 soft outlook
Source: SeekingAlpha
2026-02-04 01:05:18 ET
More on Novartis
- Novartis: Upside Increasingly Capped, 2026 Will Be A Transition Year (Rating Downgrade)
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Novartis Q4 2025 Earnings Preview
- SA analyst upgrades/downgrades: GM, UBER, UNH, NVS
Read the full article on Seeking Alpha
For further details see:
Novartis reports mixed Q4 results; initates FY26 soft outlook
Novartis AG
NASDAQ: NVS
NVS Trading
-3.68% G/L:
$144.94 Last:
615,824 Volume:
$146.92 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
